dc.contributorUniversité Laval
dc.contributorUniversity Laval
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorDalhousie University
dc.date.accessioned2022-04-28T19:42:08Z
dc.date.accessioned2022-12-20T01:19:37Z
dc.date.available2022-04-28T19:42:08Z
dc.date.available2022-12-20T01:19:37Z
dc.date.created2022-04-28T19:42:08Z
dc.date.issued2021-07-01
dc.identifierMembranes, v. 11, n. 7, 2021.
dc.identifier2077-0375
dc.identifierhttp://hdl.handle.net/11449/222057
dc.identifier10.3390/membranes11070528
dc.identifier2-s2.0-85111273791
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5402187
dc.description.abstractNatural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration membrane (EDUF), and to identify peptides responsible for these bioactivities. Two EDUF configurations (1 and 2) were used to concentrate anionic and cationic peptides, respectively. After EDUF separation, two fractions demonstrated interesting properties: the initial fraction of the EDUF configuration 1 and the final fraction of the EDUF configuration 2 both showed biological activities to (1) increase glucose uptake in L6 muscle cells in insulin condition at 1 ng/mL (by 12% and 21%, respectively), (2) decrease hepatic glucose production in hepatic cells at 1 ng/mL in basal (17% and 16%, respectively), and insulin (25% and 34%, respectively) conditions, and (3) decrease LPS-induced inflammation in macrophages at 1 g/mL (45% and 30%, respectively). More impressive, the initial fraction of the EDUF configuration 1 (45% reduction) showed the same effect as the phenformin at 10 µM (40%), a drug used to treat T2D. Thirteen peptides were identified, chemically synthesized, and tested in-vitro for these three bioactivities. Thus, four new bioactive peptides were identified: IPVE increased glucose uptake by muscle cells, IVDI and IEGTL decreased hepatic glucose production (HGP) of insulin, whereas VAPEEHPTL decreased HGP under both basal condition and in the presence of insulin. To the best of our knowledge, this is the first time that (1) bioactive peptide fractions generated after separation by EDUF were demonstrated to be bioactive on three different criteria; all involved in the T2D, and (2) potential sequences involved in the improvement of glucose uptake and/or in the regulation of HGP were identified from a salmon protein hydrolysate.
dc.languageeng
dc.relationMembranes
dc.sourceScopus
dc.subjectAnti-inflammatory activity
dc.subjectBioactive peptides
dc.subjectElectrodialysis with filtration membrane
dc.subjectGlucose uptake
dc.subjectHepatic glucose production
dc.subjectSalmon protein hydrolysate
dc.titleGlucoregulatory and anti-inflammatory activities of peptide fractions separated by electrodialysis with ultrafiltration membranes from salmon protein hydrolysate and identification of four novel glucoregulatory peptides
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución